Developing an iPS cell therapy for genetic skin disease : co

Stanford University researchers reproducibly grew clinical-grade iPSC’s

Related Keywords

Marius Wernig , Pathology Stem Cell Institute , Stanford University , Industry News , Professor Marius Wernig , Epidermolysis Bullosa , Professor Wernig , Induced Pluripotent Stem , Embryonic Stem , Developing An Ips Cell Therapy For Genetic Skin Disease Amsbio Stem Cells , Cell Therapy , Disease ,